DavidDuaneHurdMD

Oncology • Winston-Salem, NC

Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ

Join to view full profile

Dr. Hurd is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hurd's full profile

Already have an account?

Office
Medical Center Blvd
Winston-Salem, NC 27157
Phone+1 336-716-2255
Is this information wrong?

Education & Training

University of MinnesotaResidency, Internal Medicine, 1976 - 1978
University of MinnesotaInternship, Internal Medicine, 1974 - 1975
University of Illinois College of MedicineClass of 1974

Certifications & Licensure

NC State Medical License 1989 - 2024
MN State Medical License 1975 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Top MD Consumers Checkbook

Clinical Trials

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer Start of enrollment: 1996 Jun 01
Completed
Phase 3
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer Start of enrollment: 1993 Feb 01
Completed
Phase 2
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy Start of enrollment: 2008 Aug 01
Completed
Phase 2
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma Start of enrollment: 2010 Sep 01
Completed
Phase 2
Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma Start of enrollment: 2011 Apr 28
Completed
Phase 1
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen Start of enrollment: 2001 May 21
Recruiting
Join now to see all

Publications & Presentations

PubMed

A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D Hurd, Amanda F Cashen, Kristie A Blum, Andre Goy, Timothy S Fenske, Nina D Wagner-Johnston, Ke...> ;Haematologica. 2024 Mar 1
3 citations
A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma
Lauren Shea, Marcus Watkins, Fei Wan, Amanda F. Cashen, Nina D. Wagner-Johnston, Meagan A. Jacoby, Camille N. Abboud, John F. DiPersio, David D. Hurd, Samantha Jaglows...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
18 citations
Bortezomib Consolidation or Maintenance Following Immunochemotherapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: CALGB/Alliance 50403.
Lawrence D. Kaplan, Matthew J. Maurer, Wendy Stock, Nancy L. Bartlett, Noreen Fulton, Adam Pettinger, John C. Byrd, Kristie A. Blum, Ann S. LaCasce, Eric D. Hsi, Yi Ti...> ;American Journal of Hematology. 2020 Mar 13
23 citations
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients wi...
Ravi Vij, Jennifer Le-Rademacher, Kristina Laumann, Vera Hars, Kouros Owzar, Tsiporah B. Shore, Sumithira Vasu, Amanda F. Cashen, Luis Isola, Thomas B. Shea, M deMagal...> ;Biology of Blood and Marrow Transplantation. 2019 Oct 1
12 citations
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retr...
Zanetta S. Lamar, Andrew Dothard, Le Anne Kennedy, Scott Isom, Mac B. Robinson, Rakhee Vaidya, David D. Hurd, Donald A. McClain, Glenn J. Lesser> ;Leukemia & Lymphoma. 2018 Aug 1
59 citations
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna, Scott Isom, Lais P. Ghiraldeli, Lance D. Miller, Jeff W. Chou, Guangxu Jin, Wei Zhang, Leslie R. Ellis, Dmit...> ;Clinical Cancer Research. 2018 Feb 6
117 citations
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a...
Sarah A. Holstein, Sin-Ho Jung, Paul G. Richardson, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij...> ;The Lancet. Haematology. 2017 Sep 1
11 citations
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma
Peter M. Voorhees, Cristina Gasparetto, Dominic T. Moore, Diane Winans, Robert Z. Orlowski, David D. Hurd> ;Clinical Lymphoma, Myeloma & Leukemia. 2017 Jul 1
8 citations
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin ...
Zanetta S. Lamar, Nora F. Fino, Jodi Palmer, Lindsey Gruber, Bonny B. Morris, Olga Raetskaya-Solntseva, LeAnne Kennedy, Rakhee Vaidya, David D. Hurd, Kenneth Zamkoff> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Feb 1
12 citations
Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
Zanetta S. Lamar, LeAnne Kennedy, Brooke Kennedy, Mary B. Lynch, Amanda Goad, David D. Hurd, Zachariah A. McIver> ;Clinical Case Reports. 2015 Jul 1
4 citations
Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.
Kathryn M. Greven, L.D. Case, Lawrence Nycum, Patricia Zekan, David D. Hurd, Ernie P. Balcueva, Glenn Mills, Robin Zon, Patrick J. Flynn, David D. Biggs, Edward G. Sha...> ;The Journal of Community and Supportive Oncology. 2015 Mar 1
2 citations
Hematopoietic stem cell transplant candidate and designated proxy distress levels prior to hematopoietic stem cell transplantation.
Katharine E. Duckworth, Allison M. Forti, Gregory B. Russell, Seema Naik, David D. Hurd, Richard P. McQuellon> ;The American Journal of Hospice & Palliative Care. 2014 Dec 1
7 citations
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)
Xiaofeng Wang, Kouros Owzar, Pankaj Gupta, Richard A. Larson, Flora Mulkey, Antonius A. Miller, Lionel D. Lewis, David D. Hurd, Ravi Vij, Mark J. Ratain, Daryl J. Murry> ;British Journal of Clinical Pharmacology. 2014 Nov 1
18 citations
The process of advance care planning in HCT candidates and proxies: self-efficacy, locus of control, and anxiety levels.
Katharine E. Duckworth, Allison M. Forti, Gregory B. Russell, Seema Naik, David D. Hurd, Richard P. McQuellon> ;The American Journal of Hospice & Palliative Care. 2014 Nov 1
73 citations
A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
Timothy S. Pardee, King Chung Lee, John Luddy, Claudia Maturo, Robert J. Rodriguez, Scott Isom, Lance D. Miller, Kristin Stadelman, Denise Levitan, David D. Hurd, Lesl...> ;Clinical Cancer Research. 2014 Oct 15
19 citations
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (...
Pankaj Gupta, Flora Mulkey, Robert P. Hasserjian, Ben L. Sanford, Ravi Vij, David D. Hurd, Olatoyosi Odenike, Clara D. Bloomfield, Kouros Owzar, Richard Stone, Richard...> ;Investigational New Drugs. 2013 May 23
833 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The New England Journal of Medicine. 2012 May 9
137 citations
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
Wyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David D. Hurd, Jeffrey L. Johnson, S. Eric Martin, Myron S. Czuczman, Raymond Lai, Jonathan W. Said, Amy Chadburn, Dan...> ;Haematologica. 2012 May 1
49 citations
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
Clemens M. Wendtner, Peter Hillmen, Daruka Mahadevan, Andreas Bhler, Lutz Uharek, Steven Coutre, Olga Frankfurt, Adrian Bloor, Francesc Bosch, Richard R. Furman, Eva K...> ;Leukemia & Lymphoma. 2012 Mar 1
10 citations
A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia.
Kevin P. High, Doug Case, David D. Hurd, Bayard L. Powell, Glenn J. Lesser, Ann R. Falsey, Robert D. Siegel, Joanna Metzner-Sadurski, John C. Krauss, Bernard Chinnasam...> ;The Journal of Supportive Oncology. 2012 Jan 23
142 citations
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.
Todd A. Fehniger, Sarah Larson, Kathryn Trinkaus, Marilyn J. Siegel, Amanda F. Cashen, Kristie A. Blum, Timothy S. Fenske, David D. Hurd, Andre Goy, Stephanie Schneide...> ;Blood. 2011 Nov 10
A validation study of new cryopreservation bags for implementation in a blood and marrow transplant laboratory.
Gregory J. Pomper, Emily Wilson, Scott Isom, David D. Hurd> ;Transfusion. 2011 Jun 1
Altered mitochondrial metabolism as a target in acute myeloid leukemia.
Pardee TS, Levitan DA, Hurd DD> ;J. Clin. Oncol.. 2011-05-20
Does L-arginine/Korean ginseng/gingko biloba/damiana-based supplement improve the sexual function and quality of life of female cancer survivors: A randomized trial.
Greven K, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG> ;J. Clin. Oncol.. 2011-05-20
30 citations
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation
Sergio Giralt, K.F. Mangan, Richard T. Maziarz, J.S. Bubalo, Roy A. Beveridge, David D. Hurd, F.L. Mendoza, E. B. Rubenstein, T. J. DeGroot, M.W. Schuster> ;Annals of Oncology. 2011 Apr 1
Join now to see all

Lectures

Bortezomib Maintenance (BM) or Consolidation (BC) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (ASCT) for Untreated Mantle Cell Lymphoma...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Vaccination Mandates for Healthcare Workers: Updates from 4 StatesNovember 2nd, 2021
Empire State Weekly: Federal Judge Blocks Health Care Vaccine MandateOctober 15th, 2021
Federal Judge: Religious Vaccine Exemption Stays for New York Health Care WorkersOctober 12th, 2021
Join now to see all

Grant Support

Clinical Trial: Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2008–2010
Cancer And Leukemia Group BNational Cancer Institute1999–2008
Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2007
Detection Of MDS Using Fish In Pretransplant SamplesNational Cancer Institute2001–2002
Cancer And Leukemia Group BNational Cancer Institute1998